India · Delayed Price · Currency is INR Mphasis Earnings Call Transcripts
Fiscal Year 2026
-
Q4 FY 2026 saw robust AI-led growth, record TCV wins, and margin expansion, with direct business and BFS/insurance verticals leading performance. FY 2027 guidance targets high single- to low double-digit growth and stable margins, supported by continued investments in AI platforms.
-
Q3 FY26 delivered strong revenue and margin performance, driven by AI-led transformation and robust deal wins, especially in BFSI and insurance. The AI platform NeoIP now underpins a majority of the pipeline, with large deal momentum and margin discipline supporting a positive outlook.
-
Q2 FY26 delivered record revenue and EPS, with strong growth in insurance, TMD, and BFS verticals, and robust AI-led deal wins. Pipeline and TCV reached all-time highs, supported by the launch of the NeoIP AI platform and continued margin stability.
-
Record TCV wins of $760M, 68% AI-led, drove 6.5% YoY revenue growth and stable 15.3% EBIT margin. BFS, insurance, and TMT verticals led growth, with strong deal pipeline and 2x industry growth targeted for FY26.
Fiscal Year 2025
-
Q4 FY 2025 saw record sequential revenue growth, robust AI-led deal momentum, and highest-ever EPS, with strong performance in BFS and TMT. The outlook for FY 2026 is positive, targeting above-industry growth and continued margin discipline, despite macro uncertainties.
-
AI-led transformation and platform adoption drove record TCV wins and steady revenue growth, with BFS and TMT leading performance. Margins remained stable, and Q4 is expected to deliver the strongest sequential growth in three years, supported by a robust pipeline.
-
Q2 FY25 delivered 2.4% sequential and 5.4% year-over-year revenue growth, with strong AI-led deal momentum and margin expansion to 15.4%. BFS and TMT led broad-based growth, while the pipeline remains robust and guidance for FY25 is maintained.
-
Q1 FY25 saw 3.1% YoY revenue growth and a 15% EBIT margin, with strong TCV wins and a robust pipeline. AI-led platforms and modernization drive future growth, while margin guidance remains at 14.6%-16%. Healthcare is expected to recover after project completions.